These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The relationship between radiation-induced G(1)arrest and chromosome aberrations in Li-Fraumeni fibroblasts with or without germline TP53 mutations. Boyle JM; Spreadborough A; Greaves MJ; Birch JM; Varley JM; Scott D Br J Cancer; 2001 Jul; 85(2):293-6. PubMed ID: 11461092 [TBL] [Abstract][Full Text] [Related]
5. Li-Fraumeni and Li-Fraumeni-like syndrome mutations in p53 are associated with exonic methylation and splicing regulatory elements. Kouidou S; Malousi A; Maglaveras N Mol Carcinog; 2009 Oct; 48(10):895-902. PubMed ID: 19367569 [TBL] [Abstract][Full Text] [Related]
6. A peroxisome proliferator-activated receptor-gamma agonist and the p53 rescue drug CP-31398 inhibit the spontaneous immortalization of breast epithelial cells. Herbert BS; Pearce VP; Hynan LS; LaRue DM; Wright WE; Kopelovich L; Shay JW Cancer Res; 2003 Apr; 63(8):1914-9. PubMed ID: 12702583 [TBL] [Abstract][Full Text] [Related]
7. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations. Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465 [TBL] [Abstract][Full Text] [Related]
8. Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations. Liu PK; Kraus E; Wu TA; Strong LC; Tainsky MA Oncogene; 1996 Jun; 12(11):2267-78. PubMed ID: 8649766 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation. Capponcelli S; Pedrini E; Cerone MA; Corti V; Fontanesi S; Alessio M; Bachi A; Soddu S; Ribatti D; Picci P; Helman LJ; Cantelli-Forti G; Sangiorgi L Hum Mutat; 2005 Aug; 26(2):94-103. PubMed ID: 15977174 [TBL] [Abstract][Full Text] [Related]
10. Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family. Sherif ZA; Danielsen M Cancer Genet Cytogenet; 2006 Jul; 168(1):50-8. PubMed ID: 16772121 [TBL] [Abstract][Full Text] [Related]
11. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization. Bischoff FZ; Yim SO; Pathak S; Grant G; Siciliano MJ; Giovanella BC; Strong LC; Tainsky MA Cancer Res; 1990 Dec; 50(24):7979-84. PubMed ID: 2253239 [TBL] [Abstract][Full Text] [Related]
12. Chromosome instability is a predominant trait of fibroblasts from Li-Fraumeni families. Boyle JM; Mitchell EL; Greaves MJ; Roberts SA; Tricker K; Burt E; Varley JM; Birch JM; Scott D Br J Cancer; 1998 Jun; 77(12):2181-92. PubMed ID: 9649131 [TBL] [Abstract][Full Text] [Related]
13. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995 [TBL] [Abstract][Full Text] [Related]
14. Most spontaneous tumors in a mouse model of Li-Fraumeni syndrome do not have a mutator phenotype. Hill KA; Buettner VL; Heidt A; Chen LL; Li W; Gonzalez KD; Wang JC; Scaringe WA; Sommer SS Carcinogenesis; 2006 Sep; 27(9):1860-6. PubMed ID: 16597646 [TBL] [Abstract][Full Text] [Related]
15. Delayed chromosome changes in gamma-irradiated normal and Li-Fraumeni fibroblasts. Boyle JM; Spreadborough AR; Greaves MJ; Birch JM; Varley JM; Scott D Radiat Res; 2002 Feb; 157(2):158-65. PubMed ID: 11835679 [TBL] [Abstract][Full Text] [Related]
16. Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Rogan EM; Bryan TM; Hukku B; Maclean K; Chang AC; Moy EL; Englezou A; Warneford SG; Dalla-Pozza L; Reddel RR Mol Cell Biol; 1995 Sep; 15(9):4745-53. PubMed ID: 7651392 [TBL] [Abstract][Full Text] [Related]
17. Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome. Wu CC; Shete S; Amos CI; Strong LC Cancer Res; 2006 Aug; 66(16):8287-92. PubMed ID: 16912210 [TBL] [Abstract][Full Text] [Related]
18. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208 [TBL] [Abstract][Full Text] [Related]
19. Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome. Tabori U; Nanda S; Druker H; Lees J; Malkin D Cancer Res; 2007 Feb; 67(4):1415-8. PubMed ID: 17308077 [TBL] [Abstract][Full Text] [Related]
20. Radiation-induced G1 arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations. Boyle JM; Greaves MJ; Camplejohn RS; Birch JM; Roberts SA; Varley JM Br J Cancer; 1999 Apr; 79(11-12):1657-64. PubMed ID: 10206274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]